Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 2.54% is 93% below its 5-year average of 37.48%, near the low end of its 5-year range (1.68%–440.27%).
As of the fiscal period ended Tuesday, June 30, 2026. 59.04% below its 12-month average of 6.20%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.54%.
DEBT TO ASSETS RATIO
2.54%
DEBT TO ASSETS RATIO AVG TTM
6.20%
DEBT TO ASSETS RATIO AVG 3Y
21.36%
DEBT TO ASSETS RATIO AVG 5Y
37.48%
DEBT TO ASSETS RATIO AVG 10Y
42.81%
DEBT TO ASSETS RATIO AVG 15Y
30.56%
DEBT TO ASSETS RATIO AVG 20Y
28.23%
CURRENT VS TTM AVG
-59.04%
CURRENT VS 3Y AVG
-88.11%
CURRENT VS 5Y AVG
-93.23%
CURRENT VS 10Y AVG
-94.07%
CURRENT VS 15Y AVG
-91.69%
CURRENT VS 20Y AVG
-91.01%
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 465 covered companies
CURRENT VS SECTOR MEDIAN
+2208.05%
vs the sector median at left
CAMP4 Therapeutics Corporation
Market Cap
$251.64M
Debt to Assets Ratio
2.54%
TTM Avg
6.20%
3Y Avg
21.36%
5Y Avg
37.48%
Market Cap
$248.21M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$245.65M
Debt to Assets Ratio
9.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$244.25M
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$259.30M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$264.05M
Debt to Assets Ratio
0.13%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CAMP4 Therapeutics Corporation (CAMP) | $251.64M | 2.54% | 6.20% | 21.36% | 37.48% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $248.21M | 0.00% | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $247.45M | 0.00% | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $245.65M | 9.29% | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $244.25M | 0.15% | N/A | N/A | N/A |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.30M | 0.01% | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $239.89M | 0.33% | N/A | N/A | N/A |
| BioAge Labs Inc. (BIOA)vs › | $239.45M | 0.01% | N/A | N/A | N/A |
| Anika Therapeutics, Inc. (ANIK)vs › | $264.05M | 0.13% | N/A | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $264.07M | 0.00% | N/A | N/A | N/A |
Debt/Assets
2.5%
Debt/Equity
N/A
Current Ratio
4.70
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 2.54% |
| 2026-03-31 | 2.01% |
| 2025-12-31 | 1.68% |
| 2025-09-30 | 10.87% |
| 2025-06-30 | 13.89% |
| 2025-03-31 | 12.54% |
| 2024-12-31 | 11.04% |
| 2024-09-30 | 44.23% |
| 2024-06-30 | 34.15% |
| 2024-03-31 | 35.13% |
| 2023-12-31 | 440.27% |
| 2023-08-31 | 66.83% |
| 2023-05-31 | 65.58% |
| 2023-02-28 | 64.54% |
| 2022-11-30 | 63.41% |
| 2022-08-31 | 64.53% |
| 2022-05-31 | 65.73% |
| 2022-02-28 | 52.52% |
| 2021-11-30 | 51.99% |
| 2021-08-31 | 48.91% |
| 2021-05-31 | 48.33% |
| 2021-02-28 | 46.92% |
| 2020-11-30 | 47.71% |
| 2020-08-31 | 48.99% |
| 2020-05-31 | 47.75% |
| 2020-02-29 | 47.29% |
| 2019-11-30 | 42.90% |
| 2019-08-31 | 50.02% |
| 2019-05-31 | 49.90% |
| 2019-02-28 | 45.71% |
| 2018-11-30 | 44.80% |
| 2018-08-31 | 44.03% |
| 2018-05-31 | 31.66% |
| 2018-02-28 | 32.62% |
| 2017-11-30 | 32.05% |
| 2017-08-31 | 33.75% |
| 2017-05-31 | 34.80% |
| 2017-02-28 | 36.02% |
| 2016-11-30 | 36.01% |
| 2016-08-31 | 34.10% |
| 2016-05-31 | 33.25% |
| 2016-02-29 | 36.37% |
| 2015-11-30 | 37.29% |
| 2015-08-31 | 36.70% |
| 2015-05-31 | 37.60% |
| 2015-02-28 | 0.34% |
| 2014-11-30 | 0.39% |
| 2014-08-31 | 0.58% |
| 2014-05-31 | 0.92% |
| 2014-02-28 | 1.04% |
| 2013-11-30 | 1.43% |
| 2013-08-31 | 4.30% |
| 2013-05-31 | 4.71% |
| 2013-02-28 | 3.11% |
| 2012-11-30 | 7.35% |
| 2012-08-31 | 8.32% |
| 2012-05-31 | 8.77% |
| 2012-02-28 | 5.83% |
| 2011-11-26 | 12.04% |
| 2011-08-27 | 15.22% |
| 2011-05-28 | 18.22% |
| 2011-02-28 | 21.54% |
| 2010-08-28 | 22.22% |
| 2010-05-29 | 21.87% |
| 2010-02-28 | 17.68% |
| 2009-11-28 | 24.47% |
| 2009-08-29 | 24.51% |
| 2009-05-30 | 27.30% |
| 2009-02-28 | 30.26% |
| 2008-11-29 | 23.39% |
| 2008-08-30 | 23.08% |
| 2008-05-31 | 23.03% |
| 2008-03-01 | 22.74% |
| 2007-12-01 | 20.54% |
| 2007-09-01 | 14.86% |
| 2007-06-02 | 14.75% |
| 2007-03-03 | 14.91% |
| 2006-11-30 | 15.96% |
| 2006-08-31 | 17.46% |
| 2006-05-31 | 17.38% |
| 2006-02-28 | 3.76% |
| 2005-11-30 | 4.06% |
| 2005-08-31 | 4.64% |
| 2005-05-31 | 4.92% |
| 2005-02-28 | 5.38% |
| 2004-11-30 | 5.69% |
| 2004-08-31 | 6.08% |
| 2004-05-31 | 6.67% |
| 2004-02-28 | 11.57% |
| 2003-11-30 | 14.15% |
| 2003-08-31 | 16.73% |
| 2003-05-31 | 19.04% |
| 2003-03-01 | 17.38% |
| 2002-11-30 | 18.20% |
| 2002-08-31 | 19.93% |
| 2002-05-31 | 20.93% |
